A Bicentric, Randomized, Double Blind, Placebo-controlled Pilot Study to Evaluate the Efficacy and Safety of Satralizumab in FSHD1

Conditions: Facioscapulohumeral Muscular Dystrophy 1 Interventions: Drug: Satralizumab Prefilled Syringe; Drug: Placebo Comparator Sponsors: Centre Hospitalier Universitaire de Nice Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials